Video Journal of Biomedicine publishes ‘In Their Own Words’ interview with pioneering neuroscientist Professor John Hardy
‘In Their Own Words’ is a new video series from the Video Journal of Biomedicine that publishes interviews with pioneers in science discussing their life and the influences that led them to their ground-breaking research
In the first video in this series, world-leading neurogeneticist Professor John Hardy, University College London, discusses his work in the genetic causes neurodegenerative diseases and what inspired him to undertake a career in this field:
“What is the most exciting thing is for suddenly you to understand something which you know that you have not understood before. And no one else has understood before. And suddenly, over a period of an hour or two, the scales drop from your eyes. And the things– finding amyloid mutations was like that.”
Joanne Walker, Publisher, Video Journal of Biomedicine explains “Professor John Hardy is an inspiring pioneer in his field, having made ground-breaking discoveries into the genetic causes of Alzheimer’s disease and neurodegenerative diseases. We are delighted and honoured that Professor Hardy was able to share his life experiences with us. It is clear from this interview that Professor Hardy is passionate about this work and I hope that others will become inspired themselves by watching the video.”
Watch the video in full or listen to the podcast at https://www.biomedicine.video/in-their-own-words
About the Video Journal of Biomedicine
Recognising the need to help researchers explain their work through engaging content, the Video Journal of Biomedicine features high-quality, interview-style videos, filmed and edited in-house, enabling authors and researchers to personally discuss their latest work and published articles. For more information visit www.biomedicine.video
About Future Science Group
Founded in 2001, FSG is a progressive publisher focused on breakthrough medical, biotechnological and scientific research. Future Science Group’s portfolio consists of three publishing imprints, Future Science, Future Medicine, Newlands Press, as well as a content development imprint, PharmaPlatforms. In addition to this core publishing business, FSG develops specialist knowledge networks and content hubs, enabling professionals to easily connect and collaborate with their peers in niche scientific fields.
FSG currently publishes 35 peer-reviewed journals as well as 8 knowledge networks and content hubs across a wide range of therapy area and scientific fields. Key journals include Future Microbiology, Future Oncology and the Journal of Comparative Effectiveness Research, alongside sites such as Infectious Diseases Hub, Oncology Central and The Evidence Base.
The aim of FSG is to service the advancement of clinical practice and drug research by enhancing the efficiency of communications among clinicians, researchers and decision-makers, and by providing innovative solutions to their information needs. This is achieved through a customer-centric approach, use of new technologies, products that deliver value-for-money and uncompromisingly high standards.